Diagnostic options · UAE

Genetic tests in Dubai & UAE

Compare available Genetic tests, their listed prices and the information provided for each option. Test selection and preparation should be discussed with your clinician.

Tests in this category

805

Listed price range

600.00–30,000.00 AED

Clinical preparation

Confirm test-specific instructions with your clinician or laboratory.

Compare available tests

Genetic test prices

Showing 331–345 of 805 matching tests.

Genetic diagnostic tests, details, and listed prices
Test and description	Specimen	Typical duration	Price	Options
TEST-5579 GRID2 Gene Schizophrenia Genetic Test This test evaluates the GRID2 gene for pathogenic variants associated with an increased risk of developing schizophrenia.	Peripheral whole blood, extracted DNA, or dried blood spot (FTA card)	3–4 weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the GRID2 gene", "Glutamatergic signaling pathway integrity"] Parameters [] Preparation [] Indications ["Risk assessment for schizophrenia susceptibility", "Genetic counseling for individuals with family history"] Measurement technique Confirm with laboratory Codes LOINC: 103204-6 ICD-10: F20.9 Clinical summary This test evaluates the GRID2 gene for pathogenic variants associated with an increased risk of developing schizophrenia.
TEST-5764 GRID2 Gene Spinocerebellar Ataxia Type 18 (Autosomal Recessive) Genetic Test This test identifies pathogenic variants within the GRID2 gene associated with Spinocerebellar Ataxia Type 18.	Peripheral Whole Blood, Extracted DNA, or FTA Card Specimen	3–4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the GRID2 gene", "Copy Number Variations (CNV) in the GRID2 gene"] Parameters [] Preparation ["Mandatory genetic counselling session", "Pedigree charting"] Indications ["Patients with progressive cerebellar ataxia", "Relevant family history of ataxia", "Confirmation of suspected autosomal recessive spinocerebellar ataxia type 18"] Measurement technique Confirm with laboratory Codes LOINC: 81247-9 ICD-10: G11.8 Clinical summary This test identifies pathogenic variants within the GRID2 gene associated with Spinocerebellar Ataxia Type 18.
TEST-4845 GRIN2B Gene Sequencing for Mental Retardation, Autosomal Dominant Type 6 (Genetic Test) This test identifies pathogenic variants in the GRIN2B gene associated with autosomal dominant mental retardation type 6.	Whole Blood (Peripheral Venous)	3–4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in GRIN2B gene", "Single nucleotide variants", "Small insertions/deletions", "Clinically relevant copy number changes"] Parameters [] Preparation ["No fasting required", "Ensure child is well-hydrated", "Mandatory pre-test genetic counselling session"] Indications ["Suspected autosomal dominant mental retardation type 6", "Family history of MRD6", "Need for genetic counselling regarding recurrence risk"] Measurement technique Confirm with laboratory Codes LOINC: 81261-2 ICD-10: F79 Clinical summary This test identifies pathogenic variants in the GRIN2B gene associated with autosomal dominant mental retardation type 6.
TEST-6175 GRN Gene Analysis (Ceroid Lipofuscinosis Neuronal Type 11, CLN11) Test This test identifies mutations in the GRN gene associated with Ceroid Lipofuscinosis Neuronal Type 11 (CLN11), a neurodegenerative lysosomal storage disease.	Whole blood, extracted DNA, or FTA card	3–4 weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["GRN gene sequence", "Mutations (SNVs/indels) in GRN gene"] Parameters [] Preparation ["Genetic counselling session with pedigree analysis is mandatory before sample collection."] Indications ["Confirm CLN11 diagnosis", "Monitor neurodegeneration", "Variant interpretation", "Reproductive counselling", "Initial suspicion of neurodegenerative lysosomal storage disease"] Measurement technique Confirm with laboratory Codes LOINC: 94842-2 ICD-10: E75.4 Clinical summary This test identifies mutations in the GRN gene associated with Ceroid Lipofuscinosis Neuronal Type 11 (CLN11), a neurodegenerative lysosomal storage disease.
TEST-3924 GYG2 Gene Genetic Test for Autism Spectrum Disorder This test identifies pathogenic variants in the GYG2 gene linked to autism spectrum disorder.	Whole Blood (EDTA) or Saliva	3 to 4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the GYG2 gene"] Parameters [] Preparation [] Indications ["Individuals with clinical features of autism", "Individuals with a family history of ASD"] Measurement technique Confirm with laboratory Codes LOINC: 55233-1 ICD-10: F84.0 Clinical summary This test identifies pathogenic variants in the GYG2 gene linked to autism spectrum disorder.
TEST-6359 GYS1 Gene Test This test detects pathogenic variants in the GYS1 gene associated with Glycogen Storage Disease Type 0 (muscle form).	Peripheral whole blood (EDTA tube)	3–4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the GYS1 gene", "Single nucleotide variants (SNVs)", "Insertions/deletions (indels)", "Copy number variations (CNVs)"] Parameters [] Preparation ["No specific fasting required", "No medication adjustments needed prior to test"] Indications ["Suspected Glycogen Storage Disease Type 0 (muscle form)", "Family history of GSD0", "Need for definitive molecular diagnosis"] Measurement technique Confirm with laboratory Codes LOINC: 82154-2 ICD-10: E74.09 Clinical summary This test detects pathogenic variants in the GYS1 gene associated with Glycogen Storage Disease Type 0 (muscle form).
TEST-5918 HADH Gene 3-Hydroxyacyl-CoA Dehydrogenase Deficiency Genetic Test This genetic test identifies mutations in the HADH gene associated with 3-hydroxyacyl-CoA dehydrogenase deficiency (SCHAD deficiency). It analyzes the entire coding region using Ne...	Whole Blood (EDTA) or FTA Card	3–4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the HADH gene", "Coding exons and splice sites of the HADH gene"] Parameters [] Preparation ["No specific fasting required", "Do not discontinue prescribed medications or specialized diets without consulting a physician"] Indications ["Suspected SCHAD deficiency", "Symptomatic children with fasting hypoglycemia", "At-risk siblings of affected individuals", "Metabolic decompensation"] Measurement technique Confirm with laboratory Codes LOINC: 81614-3 ICD-10: E71.3 Clinical summary This genetic test identifies mutations in the HADH gene associated with 3-hydroxyacyl-CoA dehydrogenase deficiency (SCHAD deficiency). It analyzes the entire coding region using Next-Generation Sequencing (NGS).
TEST-1410 Haptoglobin Genotyping Test This genetic test identifies the specific haptoglobin genotype (HP1-1, HP2-1, or HP2-2) inherited by the patient.	Whole Blood (EDTA)	8 Working Days	850.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Haptoglobin protein genetic variant", "Cardiovascular risk predisposition"] Parameters [] Preparation ["No fasting required", "Continue all prescribed medications"] Indications ["Cardiovascular risk assessment", "Personalized preventive strategies", "Anti-aging protocols"] Measurement technique Confirm with laboratory Codes LOINC: 55531-4 ICD-10: Z13.89 Clinical summary This genetic test identifies the specific haptoglobin genotype (HP1-1, HP2-1, or HP2-2) inherited by the patient.
TEST-5474 HARS2 Gene Perrault Syndrome Type 2 Genetic Test This test identifies pathogenic mutations in the HARS2 gene associated with Perrault Syndrome Type 2.	Whole Blood, Extracted DNA, or FTA Card	3 to 4 weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["HARS2 gene mutations", "Pathogenic variants"] Parameters [] Preparation [] Indications ["Suspected Perrault Syndrome Type 2", "Family history of Perrault Syndrome Type 2", "Genetic counseling for reproductive planning"] Measurement technique Confirm with laboratory Codes LOINC: 91703-3 ICD-10: H90.5, Q87.8 Clinical summary This test identifies pathogenic mutations in the HARS2 gene associated with Perrault Syndrome Type 2.
TEST-3338 HBG2 Gene (Transient Neonatal Cyanosis) Genetic Test This genetic test evaluates the HBG2 gene for pathogenic variants associated with transient neonatal cyanosis.	Peripheral whole blood (heel-prick or venous)	3–4 weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["HBG2 gene variants", "Pathogenic variants", "Variants of Uncertain Significance (VUS)"] Parameters [] Preparation ["None specified"] Indications ["Infants with cyanotic episodes", "Suspicion of hemoglobinopathy", "Need for definitive diagnosis to reassure families"] Measurement technique Confirm with laboratory Codes LOINC: 21665-1 ICD-10: Z13.71 Clinical summary This genetic test evaluates the HBG2 gene for pathogenic variants associated with transient neonatal cyanosis.
TEST-4918 HCFC1 Gene Sequencing for X-Linked Intellectual Disability Type 3 (Genetic Test) This test analyzes the HCFC1 gene for pathogenic variants associated with X-linked intellectual disability type 3 (MRX3) and cblX metabolic disorder.	Whole Blood, DNA FTA Card, or Extracted DNA	3–4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the HCFC1 gene", "Single nucleotide variants (SNVs)", "Small insertions and deletions (indels)", "Copy number variants (CNVs)"] Parameters [] Preparation ["No fasting required", "Maintain normal hydration", "Inform phlebotomist of any bleeding disorders or anticoagulant use"] Indications ["Individuals presenting with unexplained developmental delay or hypotonia", "Individuals with a family history suggestive of X-linked intellectual disability", "Female carriers seeking reproductive risk assessment"] Measurement technique Confirm with laboratory Codes LOINC: 55233-1 ICD-10: F78 Clinical summary This test analyzes the HCFC1 gene for pathogenic variants associated with X-linked intellectual disability type 3 (MRX3) and cblX metabolic disorder.
TEST-5292 HDAC8 Gene Cornelia de Lange Syndrome Type 5 Genetic Test (NGS) This genetic test analyzes the HDAC8 gene to identify mutations associated with Cornelia de Lange Syndrome type 5.	Whole Blood (EDTA) or Dried Blood Spot (FTA Card)	3–4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the HDAC8 gene"] Parameters [] Preparation [] Indications ["Suspected Cornelia de Lange Syndrome type 5", "Family history of CdLS5", "Genetic counseling for at-risk individuals"] Measurement technique Confirm with laboratory Codes LOINC: 81247-9 ICD-10: Q87.1 Clinical summary This genetic test analyzes the HDAC8 gene to identify mutations associated with Cornelia de Lange Syndrome type 5.
TEST-1425 Hemochromatosis Detection HFE Genotyping Test This test detects the presence of common genetic mutations (C282Y, H63D, S65C) in the HFE gene linked to hereditary hemochromatosis.	Whole Blood (EDTA)	2–3 Working Days	1,000.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["HFE gene variants (C282Y, H63D, S65C)", "Genetic susceptibility to iron overload"] Parameters [] Preparation ["No special preparation required for the genetic test itself.", "Overnight fast (10-12 hours) recommended if iron studies are ordered concurrently."] Indications ["Family history of hemochromatosis", "Elevated transferrin saturation", "Elevated serum ferritin", "Symptoms suggestive of iron overload"] Measurement technique Confirm with laboratory Codes LOINC: 21670-8 ICD-10: E83.11 Clinical summary This test detects the presence of common genetic mutations (C282Y, H63D, S65C) in the HFE gene linked to hereditary hemochromatosis.
TEST-6314 HEXB Gene (GM2-Gangliosidosis Type 2) Next-Generation Sequencing DNA Test This diagnostic test evaluates the HEXB gene for pathogenic variants associated with GM2-gangliosidosis type 2 (Sandhoff disease). It identifies mutations causing this rare lysosom...	Peripheral Whole Blood (EDTA)	3–4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the HEXB gene", "Single nucleotide variants (SNVs)", "Small insertions/deletions (indels)", "Copy number changes"] Parameters [] Preparation ["No specific fasting required", "Inform the lab if the patient has received an allogeneic bone marrow transplant within the last 12 months"] Indications ["Individuals with clinical suspicion of GM2-gangliosidosis type 2", "Family history of GM2-gangliosidosis type 2", "Carrier screening in high-risk populations"] Measurement technique Confirm with laboratory Codes LOINC: 94086-2 ICD-10: E75.0 Clinical summary This diagnostic test evaluates the HEXB gene for pathogenic variants associated with GM2-gangliosidosis type 2 (Sandhoff disease). It identifies mutations causing this rare lysosomal storage disorder.
TEST-6244 HFE Gene Hemochromatosis (Classic) Genetic Test This genetic test analyzes the HFE gene for mutations linked to hereditary hemochromatosis, an iron overload disorder.	Whole blood (EDTA), extracted DNA, or dried blood spot on FTA card	21–28 calendar days	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["HFE gene mutations (C282Y, H63D, S65C, rare variants)", "Genetic susceptibility to hereditary hemochromatosis"] Parameters [] Preparation ["No dietary or medication restrictions apply", "Disclose all ongoing therapies to the laboratory"] Indications ["Family history of hemochromatosis", "Elevated serum ferritin or transferrin saturation", "Symptoms suggestive of iron overload", "Screening individuals of Northern European descent"] Measurement technique Confirm with laboratory Codes LOINC: 21665-7 ICD-10: E83.110 Clinical summary This genetic test analyzes the HFE gene for mutations linked to hereditary hemochromatosis, an iron overload disorder.

Category overview

Genetic: overview

Unlocking the blueprint of your DNA provides profound, proactive insights into your family’s future and personal health risks. Integrated within our advanced Biochemistry and molecular services, specialized Genetic testing evaluates inherited traits, metabolic predispositions, and carrier statuses. Utilizing cutting-edge diagnostic technology, comprehensive genetic screening offers the vital clarity needed to safely guide tailored medical strategies and family planning. As an undisputed leader in innovation among diagnostic labs in Dubai and the UAE, DNA Labs guarantees the highest standards of strict patient confidentiality, unparalleled diagnostic precision, and rapid reporting. Empower your health decisions with certainty—book your genetic testing in UAE, coordinate a secure sample collection, or connect with our specialized genetics team today.

Before booking

Use the test details as a conversation starter

The right diagnostic option depends on your reason for testing and individual circumstances. Check the listed specimen and timing, then confirm any preparation requirements with the ordering clinician or laboratory before collection.